A new finding could lead to better treatment for breast cancer patients.
Posted at: 08/01/2012 4:36 PM
By: Benita Zahn
|
|
|
|
The study, done at Loyola University and the University of California-Irvine, finds that combining the two breast cancer drugs Arimidex and Faslodex increases survival. Usually the drugs are given separately. The study finds those getting both drugs, together, survived 6 months longer than those getting them separately.
They also had more time before the disease progressed.
